US 8921323
Methods and compositions for modulating BCL-2 family polypeptides
granted A61PA61P25/00A61P3/10
Quick answer
US patent 8921323 (Methods and compositions for modulating BCL-2 family polypeptides) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P25/00, A61P3/10, A61P35/00, A61P35/02